{"id":136697,"date":"2026-07-01T12:32:56","date_gmt":"2026-07-01T07:02:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=136697"},"modified":"2026-07-01T12:32:57","modified_gmt":"2026-07-01T07:02:57","slug":"dr-reddys-laboratories-share-price-q1-fy27-results-july-22","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/","title":{"rendered":"Dr Reddy&#8217;s Laboratories Share Price in Focus as Board Sets July 22 for Q1 FY27 Results"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Dr Reddy&#8217;s Rs 1,344.40 (-0.94%). Q1 FY27 board meeting July 22, 2026. Trading window closed June 24 to July 24. Nomura Buy, target Rs 1,740.<\/em> This is a key data point for anyone tracking the Dr Reddy&#8217;s Laboratories share price today.<\/p>\n<p>Dr Reddy&#8217;s Laboratories share price slipped 0.94 percent to Rs 1,344.40 on Wednesday as the pharmaceutical major&#8217;s trading window remains closed ahead of its Q1 FY27 results, which the board has scheduled for July 22, 2026. The stock touched an intraday low of Rs 1,339.70 during the session.<\/p>\n<p>The upcoming results will cover the quarter ended June 30, 2026, and come at a time when brokerages remain broadly constructive on the Dr Reddy&#8217;s Laboratories share price, with Nomura recently upgrading its target on the back of the company&#8217;s strategic shift toward branded generics and its consumer business.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=dr-reddys-q1-fy27-results-july-22\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#Dr_Reddys_Laboratories_Q1_FY27_Results_Date_and_Trading_Window\" title=\"Dr Reddy&#8217;s Laboratories Q1 FY27 Results Date and Trading Window\">Dr Reddy&#8217;s Laboratories Q1 FY27 Results Date and Trading Window<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#Brokerage_View_on_Dr_Reddys_Laboratories_Share_Price\" title=\"Brokerage View on Dr Reddy&#8217;s Laboratories Share Price\">Brokerage View on Dr Reddy&#8217;s Laboratories Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#Key_Corporate_Actions_Around_Dr_Reddys_Laboratories_Share_Price\" title=\"Key Corporate Actions Around Dr Reddy&#8217;s Laboratories Share Price\">Key Corporate Actions Around Dr Reddy&#8217;s Laboratories Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#FAQs_on_Dr_Reddys_Laboratories_Share_Price\" title=\"FAQs on Dr Reddy&#8217;s Laboratories Share Price\">FAQs on Dr Reddy&#8217;s Laboratories Share Price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#1_When_will_Dr_Reddys_Laboratories_announce_Q1_FY27_results\" title=\"1. When will Dr Reddy&#8217;s Laboratories announce Q1 FY27 results?\">1. When will Dr Reddy&#8217;s Laboratories announce Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#2_Why_is_Dr_Reddys_Laboratories_trading_window_closed\" title=\"2. Why is Dr Reddy&#8217;s Laboratories trading window closed?\">2. Why is Dr Reddy&#8217;s Laboratories trading window closed?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#3_What_is_Nomuras_target_price_on_Dr_Reddys_Laboratories\" title=\"3. What is Nomura&#8217;s target price on Dr Reddy&#8217;s Laboratories?\">3. What is Nomura&#8217;s target price on Dr Reddy&#8217;s Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#4_What_impacted_Dr_Reddys_Laboratories_Q4_FY26_results\" title=\"4. What impacted Dr Reddy&#8217;s Laboratories Q4 FY26 results?\">4. What impacted Dr Reddy&#8217;s Laboratories Q4 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#5_What_dividend_did_Dr_Reddys_Laboratories_declare_for_FY26\" title=\"5. What dividend did Dr Reddy&#8217;s Laboratories declare for FY26?\">5. What dividend did Dr Reddy&#8217;s Laboratories declare for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/dr-reddys-laboratories-share-price-q1-fy27-results-july-22\/#6_When_is_Dr_Reddys_Laboratories_Annual_General_Meeting\" title=\"6. When is Dr Reddy&#8217;s Laboratories&#8217; Annual General Meeting?\">6. When is Dr Reddy&#8217;s Laboratories&#8217; Annual General Meeting?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Reddys_Laboratories_Q1_FY27_Results_Date_and_Trading_Window\"><\/span><strong>Dr Reddy&#8217;s Laboratories Q1 FY27 Results Date and Trading Window<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/stocks\/drreddy\/dr-reddy's-laboratories-ltd-share-price-today\">Dr Reddy&#8217;s Laboratories<\/a> has scheduled a board meeting for July 22, 2026 to consider the company&#8217;s unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. In line with SEBI insider trading regulations, the trading window for dealing in the company&#8217;s securities has been closed from June 24, 2026 and will remain shut until 24 hours after the results are announced on July 22. Investors watching the Dr Reddy&#8217;s Laboratories share price should note this development closely.<\/p>\n<p>The Q1 FY27 print follows a Q4 and full year FY26 result in which the company&#8217;s performance was impacted by a shelf stock adjustment related to lenalidomide of Rs 453 crore, along with impairment charges on CAR-T assets and provisions related to VAT liability, which together weighed on revenue growth, gross margin and EBITDA margin for the year. This detail is central to the near term outlook on the Dr Reddy&#8217;s Laboratories share price.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Brokerage_View_on_Dr_Reddys_Laboratories_Share_Price\"><\/span><strong>Brokerage View on Dr Reddy&#8217;s Laboratories Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nomura has upgraded its target price on Dr Reddy&#8217;s Laboratories to Rs 1,740 while reiterating a Buy rating, citing the company&#8217;s strategic shift toward branded generics and consumer health as a driver of sustained earnings growth and a potential valuation re-rating over time. This is a fresh input into the Dr Reddy&#8217;s Laboratories share price debate heading into results. This is likely to remain a talking point for the Dr Reddy&#8217;s Laboratories share price in coming sessions.<\/p>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Target Price<\/th>\n<\/tr>\n<tr>\n<td>Nomura<\/td>\n<td>Buy<\/td>\n<td>Rs 1,740<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Pharma Sector Data<\/strong><\/a><\/p>\n<p><em>Quick take: the Dr Reddy&#8217;s Laboratories share price will likely stay range bound until fresh Q1 FY27 data lands on July 22.<\/em><\/p>\n<p>Patent expirations between 2026 and 2030 are seen as offering a 3 to 5 billion dollar opportunity for Indian pharmaceutical companies in generics and biosimilars, and analysts note that firms including Dr Reddy&#8217;s, Lupin and Sun Pharma will need to manage the complexities of biologics manufacturing to capture meaningful market share from this wave. This factor will continue to influence the Dr Reddy&#8217;s Laboratories share price over the next few quarters.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Corporate_Actions_Around_Dr_Reddys_Laboratories_Share_Price\"><\/span><strong>Key Corporate Actions Around Dr Reddy&#8217;s Laboratories Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Separately, Dr Reddy&#8217;s board approved a final dividend of Rs 8 per equity share for FY26 at its May results meeting, with the record date fixed for July 10, 2026, ahead of the company&#8217;s 42nd Annual General Meeting scheduled for July 23, 2026. The company also re-appointed Dr K P Krishnan as an Independent Director for a fresh five year term beginning January 2027. This is worth watching closely for anyone following the Dr Reddy&#8217;s Laboratories share price.<\/p>\n<p><em>These are the factors most likely to matter for the Dr Reddy&#8217;s Laboratories share price in the days around the results.<\/em><\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Dr Reddy&#8217;s Laboratories&#8217; live price and results updates.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Reddy&#8217;s Laboratories share price is likely to stay range bound in the near term with its trading window closed ahead of the July 22 Q1 FY27 results, even as brokerages including Nomura remain constructive on the stock&#8217;s medium term prospects following the company&#8217;s pivot toward branded generics and consumer health. Investors should treat the upcoming results, alongside the dividend record date and AGM, as the key near term catalysts for the stock. This article is for educational purposes and is not investment advice; consult a SEBI-registered investment adviser before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Dr_Reddys_Laboratories_Share_Price\"><\/span><strong>FAQs on Dr Reddy&#8217;s Laboratories Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_When_will_Dr_Reddys_Laboratories_announce_Q1_FY27_results\"><\/span><strong>1. When will Dr Reddy&#8217;s Laboratories announce Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Reddy&#8217;s Laboratories board will meet on July 22, 2026 to consider unaudited standalone and consolidated results for the quarter ended June 30, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Why_is_Dr_Reddys_Laboratories_trading_window_closed\"><\/span><strong>2. Why is Dr Reddy&#8217;s Laboratories trading window closed?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In compliance with SEBI insider trading regulations, the trading window has been closed from June 24, 2026 and will reopen 24 hours after the Q1 FY27 results are announced on July 22.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_What_is_Nomuras_target_price_on_Dr_Reddys_Laboratories\"><\/span><strong>3. What is Nomura&#8217;s target price on Dr Reddy&#8217;s Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nomura has a Buy rating on Dr Reddy&#8217;s Laboratories with a target price of Rs 1,740, citing the company&#8217;s strategic shift toward branded generics and consumer health.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_What_impacted_Dr_Reddys_Laboratories_Q4_FY26_results\"><\/span><strong>4. What impacted Dr Reddy&#8217;s Laboratories Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Q4 FY26 results were impacted by a shelf stock adjustment related to lenalidomide of about Rs 453 crore, along with impairment charges and VAT liability provisions, which weighed on revenue and margin growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_What_dividend_did_Dr_Reddys_Laboratories_declare_for_FY26\"><\/span><strong>5. What dividend did Dr Reddy&#8217;s Laboratories declare for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Reddy&#8217;s Laboratories declared a final dividend of Rs 8 per equity share for FY26, with the record date set for July 10, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"6_When_is_Dr_Reddys_Laboratories_Annual_General_Meeting\"><\/span><strong>6. When is Dr Reddy&#8217;s Laboratories&#8217; Annual General Meeting?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Reddy&#8217;s Laboratories&#8217; 42nd Annual General Meeting is scheduled for July 23, 2026, a day after the Q1 FY27 results are announced.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"When will Dr Reddy's Laboratories announce Q1 FY27 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr Reddy's Laboratories board will meet on July 22, 2026 to consider unaudited standalone and consolidated results for the quarter ended June 30, 2026.\"}},{\"@type\":\"Question\",\"name\":\"Why is Dr Reddy's Laboratories trading window closed?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In compliance with SEBI insider trading regulations, the trading window has been closed from June 24, 2026 and will reopen 24 hours after the Q1 FY27 results are announced on July 22.\"}},{\"@type\":\"Question\",\"name\":\"What is Nomura's target price on Dr Reddy's Laboratories?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Nomura has a Buy rating on Dr Reddy's Laboratories with a target price of Rs 1,740, citing the company's strategic shift toward branded generics and consumer health.\"}},{\"@type\":\"Question\",\"name\":\"What impacted Dr Reddy's Laboratories Q4 FY26 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Q4 FY26 results were impacted by a shelf stock adjustment related to lenalidomide of about Rs 453 crore, along with impairment charges and VAT liability provisions, which weighed on revenue and margin growth.\"}},{\"@type\":\"Question\",\"name\":\"What dividend did Dr Reddy's Laboratories declare for FY26?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr Reddy's Laboratories declared a final dividend of Rs 8 per equity share for FY26, with the record date set for July 10, 2026.\"}},{\"@type\":\"Question\",\"name\":\"When is Dr Reddy's Laboratories' Annual General Meeting?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr Reddy's Laboratories' 42nd Annual General Meeting is scheduled for July 23, 2026, a day after the Q1 FY27 results are announced.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr Reddy&#8217;s Laboratories share price is in focus as the board sets July 22 for Q1 FY27 results. Trading window closure, Nomura target and outlook explained.<\/p>\n","protected":false},"author":34,"featured_media":136935,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[4795],"class_list":["post-136697","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-q1-fy27-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782994456:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_title":["Dr Reddy's Laboratories Share Price in Focus"],"rank_math_description":["Dr Reddy's Laboratories share price is in focus as the board sets July 22 for Q1 FY27 results. Trading window closure, Nomura target and outlook explained."],"rank_math_focus_keyword":["Dr Reddy's Laboratories share price"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["136935"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["22701"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Dr-Reddys-Laboratories-Share-Price-in-Focus.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/136697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=136697"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/136697\/revisions"}],"predecessor-version":[{"id":136936,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/136697\/revisions\/136936"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/136935"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=136697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=136697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=136697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}